Company profile for Vivimed Labs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

In August 2013, as part of its global business strategy to complete its presence across the entire health care value chain, Vivimed completed the acquisition of a US FDA approved 1.2 billion SOD per annum manufacturing facility at Alathur near Chennai, Tamilnadu. This facility earlier belonged to the US pharma MNC Actavis (Watson) and has received US FDA approval 4 times in April 2007, April 2009, Oct 2011 and most recently in...
In August 2013, as part of its global business strategy to complete its presence across the entire health care value chain, Vivimed completed the acquisition of a US FDA approved 1.2 billion SOD per annum manufacturing facility at Alathur near Chennai, Tamilnadu. This facility earlier belonged to the US pharma MNC Actavis (Watson) and has received US FDA approval 4 times in April 2007, April 2009, Oct 2011 and most recently in Sep 2013. The plant manufacturing capacity can be expanded to 5 billion SOD per annum. This eliminates 3 to 4 years of lead time to build a green field project of this quality and getting the regulatory approvals.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
North End Road, No.2, Banjara Hills, Hyderabad, Telangana-500 034
Telephone
Telephone
+91(0)40 6608 6608
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.equitybulls.com/admin/news2006/news_det.asp?id=288058

EQUITYBULLS
10 May 2021

https://www.indiainfoline.com/article/news-sector-pharma-healthcare/vivimed-labs-receives-uzbekistan-govt-nod-for-its-two-products-stock-spurts-5-121030800129_1.html

INDIANINFOLINE
08 Mar 2021

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/vivimed-labs-gets-approval-from-uzbekistan-govt-for-two-products/articleshow/81390075.cms

INDIATIMES
07 Mar 2021

https://www.indiainfoline.com/article/news-top-story/vivimed-labs-stock-rises-2-44-as-it-receives-approval-for-six-products-120112300087_1.html

INDIAINFOLINE
23 Nov 2020

http://www.pharmabiz.com/NewsDetails.aspx?aid=130198&sid=2

PHARMABIZ
05 Aug 2020

https://www.business-standard.com/article/pti-stories/vivimed-s-uquifa-expects-euro-200-mn-revenues-in-4-yrs-118080100629_1.html

BUSINESS-STANDARD
23 Mar 2020

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Vivimed Labs and get a quotation

Vivimed Labs is a supplier offers 5 products (APIs, Excipients or Intermediates).

Find a price of Albendazole bulk with CEP offered by Vivimed Labs

Find a price of Ciprofloxacin Hydrochloride bulk with CEP offered by Vivimed Labs

Find a price of Triclosan bulk with DMF offered by Vivimed Labs

Find a price of Tropicamide bulk with CEP offered by Vivimed Labs

Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Vivimed Labs

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty